| The Hippo pathway member YAP enhances human neural crest cell fate and migration CJ Hindley, AL Condurat, V Menon, R Thomas, LM Azmitia, JA Davis, ... Scientific reports 6 (1), 23208, 2016 | 98 | 2016 |
| Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells ZJ Reitman, BR Paolella, G Bergthold, K Pelton, S Becker, R Jones, ... Nature communications 10 (1), 3731, 2019 | 62 | 2019 |
| Surface marker profiling of SH-SY5Y cells enables small molecule screens identifying BMP4 as a modulator of neuroblastoma differentiation FC Ferlemann, V Menon, AL Condurat, J Rößler, J Pruszak Scientific reports 7 (1), 13612, 2017 | 35 | 2017 |
| PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation P Khadka, ZJ Reitman, S Lu, G Buchan, G Gionet, F Dubois, DM Carvalho, ... Nature communications 13 (1), 604, 2022 | 34 | 2022 |
| Assessing disparities in medical students’ knowledge and attitude about monkeypox: a cross-sectional study of 27 countries across three continents S Abd ElHafeez, A Gebreal, MA Khalil, N Youssef, M Sallam, ... Frontiers in Public Health 11, 1192542, 2023 | 20 | 2023 |
| Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma DA Hofman, J Ruiz-Orera, I Yannuzzi, R Murugesan, A Brown, ... Molecular Cell 84 (2), 261-276. e18, 2024 | 19 | 2024 |
| FOXR2 is an epigenetically regulated pan-cancer oncogene that activates ETS transcriptional circuits JW Tsai, P Cejas, DK Wang, S Patel, DW Wu, P Arounleut, X Wei, N Zhou, ... Cancer research 82 (17), 2980-3001, 2022 | 11 | 2022 |
| Verteporfin-induced proteotoxicity impairs cell homeostasis and survival in neuroblastoma subtypes independent of YAP/TAZ expression AL Condurat, S Aminzadeh-Gohari, M Malnar, N Schider, L Opitz, ... Scientific reports 13 (1), 3760, 2023 | 6 | 2023 |
| Mutations in the non-structural protein-coding sequence of protoparvovirus H-1PV enhance the fitness of the virus and show key benefits regarding the transduction efficiency of … H Hashemi, AL Condurat, A Stroh-Dege, N Weiss, C Geiss, J Pilet, ... Viruses 10 (4), 150, 2018 | 5 | 2018 |
| DDDR-11. IDENTIFYING NEW VULNERABILITIES TO TARGET PEDIATRIC LOW-GRADE GLIOMA A Borgenvik, S Misek, J Maile, D Novikov, S Bahadur, A Apfelbaum, ... Neuro-Oncology 25 (Supplement_5), v107-v107, 2023 | 1 | 2023 |
| Genome-wide pooled CRISPR screening in neurospheres T Abid, AB Goodale, Z Kalani, M Wyatt, EM Gonzalez, KN Zhou, K Qian, ... Nature protocols 18 (7), 2014-2031, 2023 | 1 | 2023 |
| MDB-32. Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma D Hofman, J Ruiz-Orera, I Yannuzzi, R Murugesan, J van Dinter, ... Neuro-Oncology 25 (Suppl 1), i69, 2023 | 1 | 2023 |
| LGG-26. A ROLE FOR BRAF FUSION PARTNERS IN ONCOGENIC SIGNALING S Misek, A Borgenvik, R Fekade, A Zhang, T Ragnoni, A Fultineer, K Zhou, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| LGG-29. BEYOND MAPK SIGNALING-GENOME-SCALE CRISPR/CAS9 SCREENS REVEAL NEW TARGETS FOR TREATMENT OF KIAA1549:: BRAF-DRIVEN PEDIATRIC LOW-GRADE GLIOMA A Borgenvik, S Misek, A Zhang, R Fekade, T Ragnoni, A Fultineer, K Zhou, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| DIPG-20. DELINEATING MEDIATORS OF ONCOGENESIS IN FOXR2-EXPRESSING DIFFUSE MIDLINE GLIOMAS J Tsai, P Cejas, M Coppola, D Wang, S Patel, D Wu, P Arounleut, X Wei, ... Neuro-Oncology 25 (Supplement_1), i17-i17, 2023 | | 2023 |
| Dissecting mechanisms underlying FOXR2-mediated gliomagenesis in diffuse midline gliomas JW Tsai, P Cejas, M Coppola, DK Wang, S Patel, DW Wu, P Arounleut, ... Cancer Research 83 (7_Supplement), 3562-3562, 2023 | | 2023 |
| FOXR2 is an oncogenic driver across adult and pediatric cancers JW Tsai, P Cejas, DK Wang, S Patel, DW Wu, P Arounleut, X Wei, N Zhou, ... Cancer Research 82 (12_Supplement), 5730-5730, 2022 | | 2022 |
| ELUCIDATING THE ROLE OF LONG NON-CODING RNAS IN PEDIATRIC HIGH GRADE GLIOMAS JW Tsai, FPB Dubois, DK Wang, A Crane, AL Condurat, B Krug, A Brown, ... NEURO-ONCOLOGY 24, 68-69, 2022 | | 2022 |
| LGG-45. Genetic dependencies inMYB/MYBL1-driven pediatric low-grade glioma models AL Condurat, J Jones, E Gonzalez, J Doshi, K Zhou, JW Tsai, P Khadka, ... Neuro-oncology 24 (Suppl 1), i98, 2022 | | 2022 |
| LGG-59. Identifying hidden drivers of low-grade glioma tumor growth S Misek, A Fultineer, A Condurat, K Zhou, D Root, N Persky, J Boehm, ... Neuro-Oncology 24 (Suppl 1), i102, 2022 | | 2022 |
